OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 61 filers reported holding OYSTER PT PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $203,975 | -62.1% | 18,261 | -80.9% | 0.00% | – |
| Q3 2022 | $538,000 | +29.6% | 95,686 | -0.2% | 0.00% | – |
| Q2 2022 | $415,000 | -63.2% | 95,838 | -1.1% | 0.00% | – |
| Q1 2022 | $1,128,000 | -48.2% | 96,877 | -18.8% | 0.00% | – |
| Q4 2021 | $2,179,000 | +646.2% | 119,325 | +384.8% | 0.00% | – |
| Q3 2021 | $292,000 | -2.7% | 24,611 | +40.8% | 0.00% | – |
| Q2 2021 | $300,000 | -19.1% | 17,475 | -13.9% | 0.00% | – |
| Q1 2021 | $371,000 | +9.4% | 20,294 | +12.8% | 0.00% | – |
| Q4 2020 | $339,000 | -41.0% | 17,996 | -33.9% | 0.00% | – |
| Q3 2020 | $575,000 | -46.8% | 27,241 | -27.2% | 0.00% | – |
| Q2 2020 | $1,080,000 | – | 37,398 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $32,226,000 | 14.34% |
| Paradigm Biocapital Advisors LP | 987,698 | $11,497,000 | 3.04% |
| NEA Management Company, LLC | 5,925,287 | $68,970,000 | 1.99% |
| KPCB XIV Associates, LLC | 367,987 | $4,283,000 | 1.61% |
| Telemark Asset Management, LLC | 787,026 | $9,161,000 | 0.81% |
| COWEN AND COMPANY, LLC | 509,794 | $5,934,000 | 0.57% |
| RTW INVESTMENTS, LP | 2,058,504 | $23,961,000 | 0.50% |
| ACT CAPITAL MANAGEMENT, LLC | 13,500 | $157,000 | 0.17% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $12,101,000 | 0.11% |
| Wildcat Capital Management, LLC | 36,847 | $429,000 | 0.11% |